BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25050608)

  • 1. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells.
    Götze S; Coersmeyer M; Müller O; Sievers S
    Int J Oncol; 2014 Oct; 45(4):1715-23. PubMed ID: 25050608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together.
    Wawruszak A; Luszczki J; Halasa M; Okon E; Landor S; Sahlgren C; Rivero-Muller A; Stepulak A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling.
    Sikandar S; Dizon D; Shen X; Li Z; Besterman J; Lipkin SM
    Oncotarget; 2010 Nov; 1(7):596-605. PubMed ID: 21317455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.
    Dickinson M; Johnstone RW; Prince HM
    Invest New Drugs; 2010 Dec; 28 Suppl 1(Suppl 1):S3-20. PubMed ID: 21161327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Dual-Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer.
    Chen Y; Zhang S; Li Z; Yin B; Liu Y; Zhang L
    ChemMedChem; 2023 Dec; 18(23):e202300281. PubMed ID: 37821774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX1 represses canonical Wnt signaling pathway and plays dual roles during endoderm differentiation.
    Miao D; Ren J; Jia Y; Jia Y; Li Y; Huang H; Gao R
    Cell Commun Signal; 2024 Apr; 22(1):242. PubMed ID: 38664733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies.
    Tortolina L; Duffy DJ; Maffei M; Castagnino N; Carmody AM; Kolch W; Kholodenko BN; De Ambrosi C; Barla A; Biganzoli EM; Nencioni A; Patrone F; Ballestrero A; Zoppoli G; Verri A; Parodi S
    Oncotarget; 2015 Mar; 6(7):5041-58. PubMed ID: 25671297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting LGR4-Wnt activates ferroptosis and reverses drug resistance in colorectal cancer.
    Nat Cancer; 2024 Apr; 5(4):542-543. PubMed ID: 38355778
    [No Abstract]   [Full Text] [Related]  

  • 9. Organosulfur Compounds in Colorectal Cancer Prevention and Progression.
    McAlpine PL; Fernández J; Villar CJ; Lombó F
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium.
    Chen S; Yao X; Li Y; Saifudeen Z; Bachvarov D; El-Dahr SS
    Development; 2015 Mar; 142(6):1180-92. PubMed ID: 25758227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
    Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation.
    Saleh Z; Moccia MC; Ladd Z; Joneja U; Li Y; Spitz F; Hong YK; Gao T
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer.
    Vuletić A; Mirjačić Martinović K; Spasić J
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target.
    Manfreda L; Rampazzo E; Persano L
    Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation.
    Rampazzo E; Manfreda L; Bresolin S; Cani A; Mariotto E; Bortolozzi R; Della Puppa A; Viola G; Persano L
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo.
    Savvidou I; Khong T; Whish S; Carmichael I; Sepehrizadeh T; Mithraprabhu S; Horrigan SK; de Veer M; Spencer A
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Involvement of
    Quintana I; Mur P; Terradas M; García-Mulero S; Aiza G; Navarro M; Piñol V; Brunet J; Moreno V; Sanz-Pamplona R; Capellá G; Valle L
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of canonical Wnt/β-catenin signaling with protein lysine acetylation.
    You H; Li Q; Kong D; Liu X; Kong F; Zheng K; Tang R
    Cell Mol Biol Lett; 2022 Jan; 27(1):7. PubMed ID: 35033019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer.
    Zhou B; Liu D; Tan Y
    Front Cell Dev Biol; 2021; 9():719390. PubMed ID: 34938729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interaction between microRNAs and the Wnt/β-Catenin Signaling Pathway in Osteoarthritis.
    Shang X; Böker KO; Taheri S; Hawellek T; Lehmann W; Schilling AF
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.